Nestlé India shares crash over 8% as food inflation bites
Nestle India is in focus in a monetary policy development.
· LiveMint Companies
Broad-based growth across products and channels helped Nestlé India record 36% rise in profit and 20.3% jump in sales in the September…
The analysis
Nestle India reported movement of 8%, 36% and 20.3%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -1.8% on the day at ₹1,167.00, and has returned -23.3% over three months. It sits 24% below its 52-week high. The fmcg sector has moved -10.7% over the same period, so Nestle India is running 12.6 points behind its peers.
For Nestle India, the question is how much of this is already reflected in the price and how much re-rates the fmcg peer set alongside it.
Why it matters
- Rate decisions ripple straight into banks, NBFCs and every rate-sensitive sector — from real estate to autos.
Market context
- In focus: Nestle India (Nestlé India) (NESTLEIND), in FMCG.
- Over three months: Nestle India (Nestlé India) -23.3% against FMCG -10.7% (12.6 points behind).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Nestle India (Nestlé India)NESTLEIND · FMCG | ₹1,167.00 | -1.8% | -10.9% | -23.3% | -24.2% | 0.8× | — |
FMCG
1M -4.9% · 3M -10.7%
Nestle India (Nestlé India)
Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Market wrap: Shriram Finance, Nestle India, Trent, InterGlobe top gainers and losers on Nifty and Sensex on Friday
Why is VBL down 5% despite Q3 PAT jumps on double-digit volume growth?
Gold rate in India today: MCX gold falls 2.5% in a week - Buy at low price or avoid ahead of Diwali, Dhanteras 2026?
After Welcomhotel Manesar, ITC Hotels expands Delhi-NCR presence with 105-key Fortune Select Greater Noida
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings